Fed. Circ. Nixes Pfizer Bid To Keep Lipitor IP Suit In Del.

By Elaine Meyer

Law360, New York (February 05, 2010, 6:13 PM ET) -- A federal appeals court on Friday denied Pfizer Inc.'s bid to keep a patent infringement suit seeking to prevent Apotex Inc. from marketing a generic version of cholesterol drug Lipitor in the U.S. District Court for the District of Delaware.

A three-judge panel of the U.S. Court of Appeals for the Federal Circuit issued an order denying Pfizer's petition for a writ of mandamus that would have directed the District of Delaware to vacate a decision that transferred the case to the Northern District of Illinois....
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles